Table 4 The frequency of death and the reason of death in according to the presence of HF and DMT2.
Number of deceased patients | Cause of death | ||||
|---|---|---|---|---|---|
Lymphoma progression | Cardiovascular complications | Infections | Undetermined | ||
DMT2 | 22 (29%) | 8 (36.4%) | 5 (22.7%) | 2 (9.1%) | 7 (31.8%) |
HF | 14 (30%) | 4 (28.6%) | 6 (42.9%) | 0 (0%) | 4 (28.6%) |
Neither DMT2 nor HF | 44 (12%) | 19 (43.2%) | 13 (29.5%) | 0 (0%) | 12 (27.3%) |
Total | 73 (15.6%) | 28 (38.4%) | 24 (32.9%) | 2 (2.7%) | 19 (26%) |
